Alteration of cytoskeletal molecules in a human T cell line caused by continuous exposure to chrysotile asbestos

Immunobiology

Volumn 218, Issue 9, 2013, Pages 1184-1191

  Maeda, Megumi ^a,b   Chen, Ying ^c   Kumagai Takei, Naoko ^b   Hayashi, Hiroaki ^b   Matsuzaki, Hidenori ^b   Lee, Suni ^b   Hiratsuka, Jun ichi ^b   Nishimura, Yasumitsu ^b   Kimura, Yoshinobu ^a   Otsuki, Takemi ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Actin; Asbestos; Cytoskeleton; Protein expression; T cell

Indexed keywords

BETA ACTIN; BETA TUBULIN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CHRYSOTILE; COMPLEMENTARY DNA; GAMMA INTERFERON; MESSENGER RNA; MYOSIN; MYOSIN 9; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL FATE; CELL IMMORTALIZATION; CELL STRAIN; CELL STRAIN MT 2; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSKELETON; HUMAN; HUMAN CELL; LYMPHOCYTE TRANSFORMATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; TUMOR IMMUNITY; UPREGULATION;

Β-ACTIN; ASBESTOS; CYTOSKELETON; PROTEIN EXPRESSION; T CELL;

ACTINS; ASBESTOS, SERPENTINE; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CYTOSKELETAL PROTEINS; CYTOSKELETON; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; MICROARRAY ANALYSIS; MYOSINS; PROTEIN BINDING; RECEPTORS, CXCR3; TUBULIN; VIMENTIN;

EID: 84880042179     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.04.007     Document Type: Article

References (31)

1. Bott M., Brevet M., Taylor B.S., Shimizu S., Ito T., Wang L., Creaney J., Lake R.A., Zakowski M.F., Reva B., Sander C., Delsite R., Powell S., Zhou Q., Shen R., Olshen A., Rusch V., Ladanyi M. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat. Genet. 2011, 43:668-672.
2. Craighead J.E. Diseases associated with asbestos industrial products and environmental exposure. Asbestos and its Diseases 2008, 39-93. Oxford University Press, New York. J.E. Craighead, A.R. Gibbs (Eds.).
3. Craighead J.E. Non-thoracic cancers possibly resulting from asbestos exposure. Asbestos and its Diseases 2008, 130-252. Oxford University Press, New York. J.E. Craighead, A.R. Gibbs (Eds.).
4. Craighead J.E. US governmental regulatory approaches and actions. Asbestos and its Disease 2008, 317-325. Oxford University Press, New York. J.E. Craighead, A.R. Gibbs (Eds.).
5. D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol. Lett. 2000, 112,113:421-432.
6. Hayashi H., Miura Y., Maeda M., Murakami S., Kumagai N., Nishimura Y., Kusaka M., Urakami K., Fujimoto W., Otsuki T. Reductive alteration of the regulatory function of the CD4(+)CD25(+) T cell fraction in silicosis patients. Int. J. Immunopathol. Pharmacol. 2010, 23:1099-1109.
7. Huang S.X., Jaurand M.C., Kamp D.W., Whysner J., Hei T.K. Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases. J. Toxicol. Environ. Health B: Crit. Rev. 2011, 14:179-245.
8. Hyodoh F., Takata-Tomokuni A., Miura Y., Sakaguchi H., Hatayama T., Hatada S., Katsuyama H., Matsuo Y., Otsuki T. Inhibitory effects of anti-oxidants on apoptosis of a human polyclonal T-cell line, MT-2, induced by an asbestos, chrysotile-A. Scand. J. Immunol. 2005, 61:442-448.
9. Kohyama N., Shinohara Y., Suzuki Y. Mineral phases and some reexamined characteristics of the international union against cancer standard asbestos samples. Am. J. Ind. Med. 1996, 30:515-528.
10. Kumagai-Takei N., Maeda M., Chen Y., Matsuzaki H., Lee S., Nishimura Y., Hiratsuka J., Otsuki T. Asbestos induces reduction of tumor immunity. Clin. Dev. Immunol. 2011, 481439. (Epub, 2011 October 4).
11. Lemen R.A. Epidemiology of asbestos-related diseases and the knowledge that led to what is known today. Asbestos: Risk Assessment, Epidemiology, and Health Effects 2006, 201-308. CRC Press, Boca Raton, FL. R.F. Dodson, S.P. Hammar (Eds.).
12. Maeda M., Nishimura Y., Kumagai N., Hayashi H., Hatayama T., Katoh M., Miyahara N., Yamamoto S., Hirastuka J., Otsuki T. Dysregulation of the immune system caused by silica and asbestos. J. Immunotoxicol. 2010, 7:268-278.
13. Maeda M., Nishimura Y., Hayashi H., Kumagai N., Chen Y., Murakami S., Miura Y., Hiratsuka J., Kishimoto T., Otsuki T. Reduction of CXC chemokine receptor 3 in an in vitro model of continuous exposure to asbestos in a human T-cell line, MT-2. Am. J. Respir. Cell Mol. Biol. 2011, 45:470-479.
14. Maeda M., Nishimura Y., Hayashi H., Kumagai N., Chen Y., Murakami S., Miura Y., Hiratsuka J., Kishimoto T., Otsuki T. Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients. Am. J. Respir. Cell Mol. Biol. 2011, 45:795-803.
15. Matsuzaki H., Maeda M., Lee S., Nishimura Y., Kumagai-Takei N., Hayashi H., Yamamoto S., Hatayama T., Kojima Y., Tabata R., Kishimoto T., Hiratsuka J., Otsuki T. Asbestos-induced cellular and molecular alteration of immunocompetent cells and the relationship with chronic inflammation and carcinogenesis. J. Biomed. Biotechnol. 2012, (Epub, Article ID 492608). 10.1155/2012/492608.
16. Miura Y., Nishimura Y., Katsuyama H., Maeda M., Hayashi H., Dong M., Hyodoh F., Tomita M., Matsuo Y., Uesaka A., Kuribayashi K., Nakano T., Kishimoto T., Otsuki T. Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells. Apoptosis 2006, 11:1825-1835.
17. Miyoshi I., Kubonishi I., Yoshimoto S., Akagi T., Ohtsuki Y., Shiraishi Y., Nagata K., Hinuma Y. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981, 294:770-771.
18. Mizuno T., Murakami H., Fujii M., Ishiguro F., Tanaka I., Kondo Y., Akatsuka S., Toyokuni S., Yokoi K., Osada H., Sekido Y. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes. Oncogene 2012, [Epub ahead of print, January 30]. 10.1038/onc.2012.5.
19. Moazzam N., Kratzke R.A. Medico-legal and economic aspects of mesothelioma. Mesothelioma from Bench Side to Clinic 2008, 547-554. Nova Scientific Publishers Inc., New York. A. Baldi (Ed.).
20. Murakami H., Mizuno T., Taniguchi T., Fujii M., Ishiguro F., Fukui T., Akatsuka S., Horio Y., Hida T., Kondo Y., Toyokuni S., Osada H., Sekido Y. LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res. 2011, 71:873-883.
21. Nature editorial Asbestos scandal. Nature 2010, 468:868.
22. Nishimura Y., Miura Y., Maeda M., Kumagai N., Murakami S., Hayashi H., Fukuoka K., Nakano T., Otsuki T. Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers. Int. J. Immunopathol. Pharmacol. 2009, 22:579-590.
23. Nishimura Y., Maeda M., Kumagai N., Hayashi H., Miura Y., Otsuki T. Decrease in phosphorylation of ERK following decreased expression of NK cell-activating receptors in human NK cell line exposed to asbestos. Int. J. Immunopathol. Pharmacol. 2009, 22:879-888.
24. Otsuki T., Miura Y., Nishimura Y., Hyodoh F., Takata A., Kusaka M., Katsuyama H., Tomita M., Ueki A., Kishimoto T. Alterations of Fas and Fas-related molecules in patients with silicosis. Exp. Biol. Med. (Maywood) 2006, 231:522-533.
25. Otsuki T., Maeda M., Murakami S., Hayashi H., Miura Y., Kusaka M., Nakano T., Fukuoka K., Kishimoto T., Hyodoh F., Ueki A., Nishimura Y. Immunological effects of silica and asbestos. Cell. Mol. Immunol. 2007, 4:261-268.
26. Otsuki T., Maeda M., Miura Y., Hayashi H., Murakami S., Kumagai N., Nishimura Y. Immunological effects of asbestos. Asbestos: Risks, Environment and Impact 2009, 185-193. Nova Science Publishers, Inc., New York. A. Soto, G. Salazar (Eds.).
27. Rolston R., Oury T.D. Other neoplasia. Pathology of Asbestos - Associated Diseases 2004, 217-230. Springer Inc., New York. 2nd ed. V.L. Roggli, T.D. Oury, T.A. Sporn (Eds.).
28. Sekido Y. Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation. Pathol. Int. 2011, 61:331-344.
29. Steenland K., Goldsmith D.F. Silica exposure and autoimmune diseases. Am. J. Ind. Med. 1995, 28:603-608.
30. Testa J.R., Cheung M., Pei J., Below J.E., Tan Y., Sementino E., Cox N.J., Dogan A.U., Pass H.I., Trusa S., Hesdorffer M., Nasu M., Powers A., Rivera Z., Comertpay S., Tanji M., Gaudino G., Yang H., Carbone M. Germline BAP1 mutations predispose to malignant mesothelioma. Nat. Genet. 2011, 43:1022-1025.
31. Toyokuni S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci. 2009, 100:9-16.